Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection
A study published in the Aug. 22, 2022, issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent ...
Aug 22, 2022
0
37